Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?

Carlo De Innocentiis1, Marco Zimarino1, Raffaele De Caterina1

  • 1Institute of Cardiology and Centre of Excellence on Ageing, "G. d'Annunzio" University of Chieti-Pescara,Chieti, Italy.

Insights

Complete revascularization in multivessel coronary artery disease (MVCAD) offers long-term benefits but carries higher procedural risks. The choice between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) depends on patient factors and disease complexity.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Multivessel coronary artery disease (MVCAD) requires myocardial revascularization.
  • Revascularization strategies include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
  • Complete revascularization improves long-term prognosis but increases periprocedural risks compared to incomplete revascularization.

Purpose of the Study:

  • To compare the outcomes of complete versus incomplete revascularization in MVCAD.
  • To evaluate the role of CABG versus PCI in achieving optimal revascularization.
  • To discuss guideline-based recommendations for revascularization modality selection in MVCAD.

Main Methods:

  • Review of current international guidelines and clinical evidence.
  • Analysis of factors influencing the choice between PCI and CABG.
  • Consideration of coronary anatomy, ischemic burden, and patient comorbidities.

Main Results:

  • CABG often achieves more extensive revascularization than PCI in MVCAD.
  • PCI is generally preferred for single-vessel disease, low-risk MVCAD, or isolated left main disease.
  • CABG is typically recommended for complex two-vessel disease, most three-vessel disease, and non-isolated left main disease.

Conclusions:

  • The optimal revascularization strategy in MVCAD requires a multifactorial assessment.
  • Adequacy of myocardial revascularization is a critical determinant of long-term outcomes.
  • Individualized treatment decisions should balance procedural risk with the benefits of complete revascularization.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
393